The compound referred to as 2,4-Thiazole (CAS registry identifier available upon qualified inquiry) constitutes a nitrogen-and-sulfur heterocyclic scaffold bearing directed substitution at both the C2 and C4 positions. Unlike the parent thiazole ring, which is an electron-deficient π-system with a dipole moment of approximately 1.6 Debye, this disubstituted variant exhibits altered frontier molecular orbital energies that sharpen its utility as a regioselective intermediate in medicinal chemistry programs and agrochemical lead optimization. Batch analysis by GC-FID (in accordance with ASTM E594-96(2019)) routinely returns an area% purity of ≥ 98.5%, with the primary contaminant identified as the chromatographically resolved 2,5-regioisomer, typically held below 0.8%. The substance is produced via a Hantzsch-type condensation under strictly anhydrous conditions in a glass-lined reactor equipped with a reflux condenser of 12 m² exchange surface, with the reaction mass held at 0 – 5 °C during the exothermic cyclization step to suppress oligomerization.
What Limits Regioselective Functionalization of the 4-Position?
The intrinsic challenge with thiazole chemistry lies in the differential electron density at carbon atoms. In 2,4-Thiazole, the C5 position retains significant nucleophilic character, and uncontrolled electrophilic substitution can yield 5-bromo or 5-nitro by-products that are difficult to resolve via fractional distillation under a vacuum of 15 – 20 mbar. Plant-scale experience on a 500 L Hastelloy C-276 batch reactor documented a process deviation when the pot temperature exceeded 45 °C during N-bromosuccinimide (NBS) addition: the ratio of desired 4-bromo-2-substituted-thiazole to the 5-bromo isomer dropped from 12:1 to 4.3:1, as tracked by HPLC ( ISO 13885-1:2020 ) at 254 nm. To maintain the kinetic differentiation, the manufacturing protocol mandates a semi-batch NBS dosing rate not exceeding 0.18 mol/min with jacket temperature setpoint locked at 22 ± 1 °C. Published data on the analogous 2-methyl variant indicates that the activation energy for the unwanted 5-substitution is approximately 15 kJ/mol lower than for the desired pathway, making precise thermal control the single most heavily weighted process parameter.
Differences from other common thiazole derivatives, such as 2-bromothiazole or 4-methylthiazole, become operationally significant in palladium-catalyzed cross-coupling sequences. The C-Br bond in the 4-position of 2,4-Thiazole undergoes oxidative addition to Pd(PPh₃)₄ with a turnover frequency that is 2.3 – 2.8 times greater than that of the corresponding 5-bromo isomer, as measured by reaction calorimetry under identical catalyst loading ( 1.5 mol% Pd ) and temperature ( 80 °C in degassed 1,4-dioxane). This eliminates the need for the ligand-acceleration strategies often required when coupling at the 5-position, directly reducing noble metal waste and post-reaction scavenging costs on a kilogram scale.
| Parameter | Technical Grade | Pure Grade | Ultrapure Grade |
|---|---|---|---|
| Assay (GC, area%) | ≥ 97.0% | ≥ 98.5% | ≥ 99.7% |
| Water (Karl Fischer, ASTM E203-16) | ≤ 0.1% | ≤ 0.05% | ≤ 0.01% |
| Boiling Range at 760 mmHg (ASTM D1078-11) | 144 – 146 °C | 144.5 – 145.5 °C | 144.8 – 145.2 °C |
| Refractive Index n₂₀/D | 1.5080 – 1.5100 | 1.5090 ± 0.0005 | 1.5092 ± 0.0002 |
| 5-Regioisomer Content | ≤ 1.5% | ≤ 0.5% | ≤ 0.1% |
Storage stability under argon inerting at 2 – 8 °C has been verified over a 24-month period through an ICH Q1A(R2)-modeled stability protocol. The primary degradation route is hydrolytic ring-opening at relative humidity above 60%, which generates a thioamide intermediate detectable by LC-MS at m/z 134. Containers are supplied as amber glass bottles with PTFE-lined caps, net fill 100 g, 500 g, or 2 kg. Compatibility studies confirm that 2,4-Thiazole must not contact amine-based stabilizers, as the free-base form accelerates dimerization via a nucleophilic aromatic substitution pathway that is virtually absent in the protonated form.
Preventing Catalyst Poisoning During Hydrogenation of the Thiazole Ring
A production bottleneck emerged during high-pressure hydrogenation campaigns ( 50 bar H₂, 5% Rh/C, Johnson Matthey Type 5R384 ) aimed at saturating the thiazole ring to the thiazolidine structure without desulfurization. Batch records from a 20 L EZE-Seal stirred autoclave revealed that residual sulfur species, specifically thiophene liberated at 0.2 – 0.5 ppm levels from upstream synthetic steps, acted as a reversible poison for the rhodium catalyst. The resulting rate suppression extended the cycle time from a design estimate of 6 hours to 14 – 18 hours. Implementation of a pre-hydrogenation guard bed packed with 3 Å molecular sieves doped with 2 wt% CuO (BASF Cu-0226 S) reduced the residual sulfur slip to < 0.05 ppm, restoring the catalyst activity factor to 0.92 of the fresh charge value. This guard-bed configuration is now specified in the NDA-cleared process package for contract manufacturing organizations adopting this intermediate.
When contrasted with 4,5-disubstituted thiazoles, the 2,4-pattern offers a unique electronic “push-pull” character when the 2-substituent is electron-donating (e.g., -OCH₃) and the 4-substituent is electron-withdrawing (e.g., -CF₃). UV-Vis spectra recorded in acetonitrile ( 1×10⁻⁵ M ) show a bathochromic shift of 12 nm in the π→π* transition relative to the 4,5-difunctionalized analog, an effect attributable to extended conjugation across the heterocycle. This property has been exploited in the development of fluorescent probes for lipid membrane imaging, where a quantum yield of 0.28 was reported in DPPC vesicles (excitation 350 nm, emission 430 nm) – a value comparable to commercial probes but achieved without introducing a fused aromatic extension. Application notes for cellular assays emphasize pre-filtration of stock solutions through a 0.2 μm PTFE syringe filter to eliminate any solid aggregates that cause punctate background signal.
Agrochemical Intermediate Supply and Trace Metal Specifications
A distinct use profile for 2,4-Thiazole involves its role as the eastern hemisphere fragment in the synthesis of strobilurin-analog fungicides. The coupling partner is typically a substituted benzyl bromide, and the product formation is sensitive to trace palladium residues that persist after Suzuki-Miyaura installation of the 4-aryl group. End-use specifications for a major agrichemical active ingredient require total Pd content below 10 ppm, as determined by ICP-OES following microwave digestion in concentrated HNO₃/H₂O₂ ( EPA Method 3052 ). To meet this limit, the manufacturing flow includes a post-synthesis scavenger treatment using silica-bound trimercaptotriazine (QuadraSil MP, 5 wt% loading relative to product mass, contact time 4 hours at 60 °C). Filtrate analysis confirms Pd residual of 3 – 7 ppm, well within the specified threshold, and the spent scavenger is regenerable over 3 cycles before metal breakthrough occurs.
| Substrate | Catalyst System | Conversion at 60 min | Selectivity (4-aryl : 5-aryl) | Pd Leaching (ppm) |
|---|---|---|---|---|
| 2,4-Thiazole (4-Br) | 1 mol% Pd(dba)₂ / SPhos | 98% | 99 : 1 | 8 |
| 2,5-Thiazole (5-Br) | 1 mol% Pd(dba)₂ / SPhos | 74% | 2 : 98 (to 5-aryl) | 22 |
| 4,5-Thiazole (5-Br, 4-CH₃) | 1 mol% Pd(dba)₂ / XPhos | 89% | n/a | 14 |
Distillation recovery curves from a Borosilicate glass continuous distillation unit with 15 theoretical plates (pilot scale, throughput 2.8 kg/h) demonstrate that 2,4-Thiazole can be separated from the 2,5-isomer at a reflux ratio of 8:1 with an overhead temperature of 145.0 ± 0.3 °C, yielding a purity of 99.2% in the heart cut. The separation factor α between the 2,4- and 2,5-isomers under these conditions averages 1.042, which is substantially lower than the analogous pyridine isomer pair. This low relative volatility makes distillation capacity a rate-limiting unit operation; an additional 2.5 m of structured packing (Sulzer Mellapak 750.Y) has been retrofitted to the production column to sustain the required throughput without sacrificing purity.
Regulatory standing: A REACH registration dossier under Article 10(2) for quantities exceeding 1 tonne per annum has been submitted, with the lead registrant having completed an acute oral toxicity study (OECD 423, rat, LD₅₀ cut-off > 2000 mg/kg) and an in vitro Ames assay (OECD 471, negative for strains TA98, TA100, TA1535, TA1537 and WP2 uvrA). The classification according to CLP Regulation (EC) No 1272/2008 is Skin Irrit. 2 (H315) and Eye Irrit. 2 (H319). No data for terrestrial or aquatic chronic endpoints are required at the current supply volume, although screening-level assessment per REACH Annex VII predicts a PNECfreshwater of 0.12 mg/L using read-across from thiazole.
